Francesco Carpagnano

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Jean‐Yves Douillard, Rafael Rosell, Mario De Lena et al. · The Lancet Oncology · 2006 · 1.6K citations

Surgical Oncology, Cisplatin Versus Observation, Medicine +10

ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association

J.-Y. Douillard, R. Rosell, M DELENA et al. · Journal of Clinical Oncology · 2005 · 161 citations

Iiia Nsclc Pts, Surgical Oncology, Cancer Management +23

3p Microsatellite Alterations in Exhaled Breath Condensate from Patients with Non–Small Cell Lung Cancer

Giovanna Elisiana Carpagnano, Maria Pia Foschino Barbaro, Giuseppina Mulè et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 81 citations

Healthy Subjects, Advanced Lung Disease, Lung Inflammation +16

Phase I/II Study of Gemcitabine Plus Vinorelbine as First-Line Chemotherapy of Non–Small-Cell Lung Cancer

Vito Lorusso, Francesco Carpagnano, G. Frasci et al. · Journal of Clinical Oncology · 2000 · 81 citations

IL-2, TNF-α, and Leptin: Local Versus Systemic Concentrations in NSCLC Patients

Giovanna Elisiana Carpagnano, Antonio Spanevello, Claudia Curci et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2006 · 75 citations · Full text

Asthma, Advanced Lung Disease, Lung Inflammation +20